Cargando...
The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
BACKGROUND/AIMS: Before tenofovir (TDF) become available in South Korea, combination therapy with entecavir (ETV) and adefovir (ADV) was the most potent regimen for chronic hepatitis B (CHB) patients who fail to respond to rescue therapy for drug resistance. We analyzed the efficacy of ETV-ADV combi...
Gardado en:
| Publicado en: | Clin Mol Hepatol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
The Korean Association for the Study of the Liver
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4946405/ https://ncbi.nlm.nih.gov/pubmed/27304549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2015.0053 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|